Medicin - foto by Anna Shvets - Pexels
After years of underperformance, investor interest in healthcare stocks is picking up again. Although investors remain significantly underweight the sector, asset managers see the outlook improving. Biotechnology in particular appears to be entering a new phase of growth.
Continue reading this article?
Register for free and get access to Investment Officer International:
- Exclusive for professional investors
- Cancel anytime
- Unlimited access: web, app and newsletters
Registration takes less than 1 minute.
No payment details required
Register for free and get access to Investment Officer Luxembourg:
- Exclusive for professional investors
- Cancel anytime
- Unlimited access: web, app and newsletters
Registration takes less than 1 minute.
No payment details required